null

SMILES: C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1

InChI Key: InChIKey=GCPYHBLSPJNXID-KOSHJBKYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50027809   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50027809 (CHEMBL154906) Show SMILES C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C25H29ClN4O4S/c1-18(27-17-24(31)20-8-6-9-21(26)14-20)15-28-22-10-5-7-19(13-22)16-29-25(32)30-35(33,34)23-11-3-2-4-12-23/h2-14,18,24,27-28,31H,15-17H2,1H3,(H2,29,30,32)/t18-,24+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	251	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Concentration that causes 50% inhibition of human beta 2 adrenergic receptor (AR), expressed in CHO cells.				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50027809 (CHEMBL154906) Show SMILES C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C25H29ClN4O4S/c1-18(27-17-24(31)20-8-6-9-21(26)14-20)15-28-22-10-5-7-19(13-22)16-29-25(32)30-35(33,34)23-11-3-2-4-12-23/h2-14,18,24,27-28,31H,15-17H2,1H3,(H2,29,30,32)/t18-,24+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	398	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50027809 (CHEMBL154906) Show SMILES C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 Show InChI InChI=1S/C25H29ClN4O4S/c1-18(27-17-24(31)20-8-6-9-21(26)14-20)15-28-22-10-5-7-19(13-22)16-29-25(32)30-35(33,34)23-11-3-2-4-12-23/h2-14,18,24,27-28,31H,15-17H2,1H3,(H2,29,30,32)/t18-,24+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	16	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Ability to cause cAMP accumulation in CHO cells expressing human beta-3 AR expressed as the negative logarithm of the molar drug concentration				J Med Chem 45: 567-83 (2002) BindingDB Entry DOI: 10.7270/Q2W0976P
					More data for this Ligand-Target Pair